+1(646)631-6696
Journal Logo

Innovations in Molecular Biotechnology

OPEN ACCESS

Mini Review
Gene editing revolution: How CRISPR technology is transforming genetic science, medicine, and biotechnology for the future
Elsie Leong1 and Olivia Liberty2  
leong.e@yahoo.com
1 Department of Systems Biology, Columbia University, USA
2 Department of Molecular Biology, Cornell University, USA
Author Info »



ABSTRACT

Gene editing tools like CRISPR-Cas9 have become ground-breaking resources in the fields of genetic research and biotechnology. In this discussion, we will examine the core mechanisms of CRISPR, emphasizing its extraordinary capability to accurately target and alter particular DNA sequences through the Cas9 protein. When juxtaposed with earlier gene-editing techniques, the straightforwardness and effectiveness of CRISPR have opened up numerous opportunities across various areas, including healthcare, agriculture, and biotechnology. In medicine, CRISPR presents significant potential for addressing genetic disorders such as sickle cell anemia, cystic fibrosis, and Duchenne muscular dystrophy. By enabling direct correction of the fundamental genetic mutations, CRISPR could transform the methods used to tackle these diseases. Additionally, researchers are investigating its applications in cancer therapy and regenerative medicine, which may lead to substantial advancements in cancer treatment and tissue healing approaches. Similarly, CRISPR's influence in biotechnology is noteworthy. It provides innovative avenues for improving crops, livestock, and microbial organisms, allowing for the development of genetically modified entities exhibiting favorable characteristics such as resistance to diseases, increased productivity, and adaptability to environmental changes. CRISPR presents significant ethical dilemmas, particularly in editing human germlines and creating genetically modified embryos, as its long-term implications and potential unintended consequences demand careful consideration.



KEYWORDS

    1. Gene editing
    2. CRISPR-Cas9
    3. Biotechnology
    4. Genetic disorders
    5. Ethical considerations
    6. Genetic science


Author Info

Elsie Leong1 and Olivia Liberty2

1 Department of Systems Biology, Columbia University, USA
2 Department of Molecular Biology, Cornell University, USA
Corresponding author: leong.e@yahoo.com

© 2025 Reseapro Journals